Effects of Structure of Rho GTPase-activating Protein DLC-1 on Cell Morphology and Migration

被引:52
|
作者
Kim, Tai Young [1 ]
Healy, Kevin D. [1 ,2 ]
Der, Channing J. [1 ,2 ]
Sciaky, Noah [1 ]
Bang, Yung-Jue [3 ]
Juliano, Rudy L. [1 ,2 ]
机构
[1] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA
[2] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA
[3] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul 110744, South Korea
基金
美国国家卫生研究院;
关键词
D O I
10.1074/jbc.M800617200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
DLC-1 encodes a Rho GTPase-activating protein (RhoGAP) and negative regulator of specific Rho family proteins (RhoA-C and Cdc42). DLC-1 is a multi-domain protein, with the RhoGAP catalytic domain flanked by an amino-terminal sterile alpha motif (SAM) and a carboxyl-terminal START domain. The roles of these domains in the regulation of DLC-1 function remain to be determined. We undertook a structure-function analysis involving truncation and missense mutants of DLC-1. We determined that the amino-terminal SAM domain functions as an autoinhibitory domain of intrinsic RhoGAP activity. Additionally, we determined that the SAM and START domains are dispensable for DLC-1 association with focal adhesions. We then characterized several mutants for their ability to regulate cell migration and identified constitutively activated and dominant negative mutants of DLC-1. We report that DLC-1 activation profoundly alters cell morphology, enhances protrusive activity, and can increase the velocity but reduce directionality of cell migration. Conversely, the expression of the amino-terminal domain of DLC-1 acts as a dominant negative and profoundly inhibits cell migration by displacing endogenous DLC-1 from focal adhesions.
引用
收藏
页码:32762 / 32770
页数:9
相关论文
共 50 条
  • [1] DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma
    Kim, Tai Young
    Lee, Jung Weon
    Kim, Hwang-Phill
    Jong, Hyun-Soon
    Kim, Tae-You
    Jung, Mira
    Bang, Yung-Jue
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 355 (01) : 72 - 77
  • [2] DLC-1: a Rho GTPase-activating protein and tumour suppressor
    Durkin, Marian E.
    Yuan, Bao-Zhu
    Zhou, Xiaoling
    Zimonjic, Drazen B.
    Lowy, Douglas R.
    Thorgeirsson, Snorri S.
    Popescu, Nicholas C.
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (05) : 1185 - 1207
  • [3] DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development
    Durkin, ME
    Avner, MR
    Huh, CG
    Yuan, BZ
    Thorgeirsson, SS
    Popescu, NC
    FEBS LETTERS, 2005, 579 (05): : 1191 - 1196
  • [4] Rho GTPase-activating proteins in cell regulation
    Moon, SY
    Zheng, Y
    TRENDS IN CELL BIOLOGY, 2003, 13 (01) : 13 - 22
  • [5] Pseudomonas aeruginosa ExoT is a Rho GTPase-activating protein
    Krall, R
    Schmidt, G
    Aktories, K
    Barbieri, JT
    INFECTION AND IMMUNITY, 2000, 68 (10) : 6066 - 6068
  • [6] FilGAP, a Rho/Rho-associated protein kinase-regulated GTPase-activating protein for Rac, controls tumor cell migration
    Saito, Koji
    Ozawa, Yuta
    Hibino, Keisuke
    Ohta, Yasutaka
    MOLECULAR BIOLOGY OF THE CELL, 2012, 23 (24) : 4739 - 4750
  • [7] Role of the Rho GTPase-activating protein RICS in neurite outgrowth
    Nasu-Nishimura, Yukiko
    Hayashi, Tomoatsu
    Ohishi, Tomohiro
    Okabe, Toshio
    Ohwada, Susumu
    Hasegawa, Yoshimi
    Senda, Takao
    Toyoshima, Chikashi
    Nakamura, Tsutomu
    Akiyama, Tetsu
    GENES TO CELLS, 2006, 11 (06) : 607 - 614
  • [8] Rho GTPase-Activating Protein DLC2 Deficiency in Mice Leads to More Severe Painful Diabetic Neuropathy
    Tirrell, Lee S.
    Cheung, Chi Wai
    Chung, Sookja K.
    DIABETES, 2013, 62 : A147 - A147
  • [9] The role of NADRIN, a Rho GTPase-activating protein, in the morphological differentiation of astrocytes
    Kobayashi, Yoko
    Harada, Ayako
    Furuta, Birei
    Asou, Hiroaki
    Kato, Utako
    Umeda, Masato
    JOURNAL OF BIOCHEMISTRY, 2013, 153 (04): : 389 - 398
  • [10] Deleted in liver cancer 3 (DLC-3), a novel Rho GTPase-activating protein, is downregulated in cancer and inhibits tumor cell growth
    M E Durkin
    V Ullmannova
    M Guan
    N C Popescu
    Oncogene, 2007, 26 : 4580 - 4589